45 Biggest Movers From Yesterday

Gainers

  • Sorrento Therapeutics, Inc. SRNE shares gained 94.4% to close at $3.11 on Monday after the company announced it has recieved and rejected an unsolicited, all cash proposal from two biopharmaceutical companies between $3-$5 per share in cash.
  • JanOne Inc. JAN shares climbed 54.1% to close at $3.94 on Monday after the company announced it purchased a worldwide exclusive license for TV1001SR, a treatment for peripheral arterial disease. No terms were disclosed.
  • RAPT Therapeutics, Inc. RAPT gained 44.3% to close at $ 29.47 after several firms initiated coverage on the company's stock with bullish ratings.
  • The Medicines Company MDCO shares rose 22.3% to close at $83.80 after the company announced it will be acquired by Novartis AG for $85 per share.
  • Neoleukin Therapeutics, Inc. NLTX gained 22.2% to close at $4.24.
  • Zynex, Inc. ZYXI gained 20.2% to close at $10.72.
  • Clovis Oncology, Inc. CLVS rose 18.6% to close at $ 10.27 on above-average volume.
  • The Peck Company Holdings, Inc. PECK rose 17.5% to close at $2.69.
  • Aquestive Therapeutics, Inc. AQST shares rose 17.3% to close at $7.54 after the company received the FDA approval for EXSERVAN for the treatment of amyotrphic lateral sclerosis.
  • Arrowhead Pharmaceuticals Inc ARWR gained 15.8% to close at $56.99 after Baird upgraded the company's stock from Neutral to Outperform and raised the price target from $39 to $70.
  • Akebia Therapeutics, Inc. AKBA rose 15.7% to close at $4.87.
  • BioCryst Pharmaceuticals, Inc. BCRX climbed 15.1% to close at $2.59.
  • GlobalSCAPE, Inc. GSB surged 15.1% to close at $13.07.
  • Ruhnn Holding Limited RUHN rose 15% to close at $8.11.
  • Enochian Biosciences Inc. ENOB climbed 14.9% to close at $6.74.
  • InMode Ltd. INMD gained 14.7% to close at $47.66. This could potentially be a rebound after the stock the dropped approximately 23% over the past 4 trading sessions.
  • BioXcel Therapeutics, Inc. BTAI rose 13.6% to close at $6.85.
  • Hallador Energy Company HNRG rose 13.6% to close at $2.93.
  • Calithera Biosciences, Inc. CALA jumped 13.1% to close at $4.58.
  • Ferro Corporation FOE rose 13% to close at $14.36 following reports that the company could be exploring strategic options.
  • U.S. Silica Holdings, Inc. SLCA gained 12.8% to close at $5.13.
  • Chico's FAS, Inc. CHS climbed 11.5% to close at $4.18.
  • Kamada Ltd. KMDA rose 10.7% to close at $7.64.
  • ArQule, Inc. ARQL gained 9.7% to close at $8.98. The company earlier announced it will present clinical data from its Phase 1 study of ARQ 531 at the ASH Annual Meeting on December 9th.
  • Five Prime Therapeutics, Inc. FPRX climbed 9.6% to close at $3.88.
  • Zscaler, Inc. ZS shares rose 8.8% to close at $50.39 after Bank of America upgraded the company's stock from Neutral to Buy.
  • Intercept Pharmaceuticals, Inc. ICPT rose 8.4% to close at $96.34. Intercept Pharma disclosed that the FDA has accepted New Drug Application for obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis and granted priority review.
  • IVERIC bio, Inc. ISEE climbed 7.9% to close at $3.56.
  • IEC Electronics Corp. IEC shares rose 7.8% to close at $8.41.
  • Tiffany & Co. TIF rose 6.2% to close at $133.25 after LVMH confirmed an agreement to buy the company in a $16.2 billion bid.

 

Losers

  • CymaBay Therapeutics Inc CBAY shares tumbled 76.1% to close at $1.33 on Monday after the company reported a halt in the clinical development of its Seladelpar.
  • La Jolla Pharmaceutical Company LJPC fell 53.6% to close at $2.59 after the company reported that President and CEO George Tidmarsh has left the company. La Jolla Pharmaceutical disclosed that it will reassess continued development of LJPC-401 based on recent clinical results.
  • Adamis Pharmaceuticals Corp ADMP shares dropped 51% to close at $0.6179 after the company reported it received a complete response letter from the FDA for its ZIMHI. The FDA stated it cannot approve the ZIMHI in its present form and provided suggested needed for resubmission.
  • Kazia Therapeutics Limited KZIA fell 24.2% to close at $5.61 after reporting interim data from ongoing Phase 2 study of GDC-0084 in glioblastoma.
  • BlueLinx Holdings Inc. BXC fell 23.2% to close at $9.55.
  • Surface Oncology, Inc. SURF shares declined 21% to close at $1.8400 after the company reported a $25 million debt financing from K2 HealthVentures.
  • Kirkland Lake Gold Ltd KL shares dipped 17.2% to close at $39.44 after the company, along with Detour Gold, announced Kirkland Lake Gold will acquire all of the issued and outstanding securities of Detour Gold.
  • Akerna Corp. KERN dipped 15.3% to close at $6.13.
  • AMERI Holdings, Inc. AMRH shares dropped 14.6% to close at $2.3261.
  • Vislink Technologies Inc VISL tumbled 14.3% to close at $0.2530. Vislink Technologies priced its common stock and warrant offering for $4 million.
  • Wah Fu Education Group Limited WAFU fell 13.7% to close at $2.34.
  • Protagonist Therapeutics, Inc. PTGX dropped 11.9% to close at $8.34.
  • Scholar Rock Holding Corporation SRRK fell 11.3% to close at $9.38.
  • Aurora Mobile Limited JG dipped 10.5% to close at $3.00.
  • CANAAN INC. CAN fell 7.7% to close at $8.29. The stock has been volatile since Thursday's IPO, in which it opened at $12.60, above the IPO price of $9.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!